Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Murzyn, Anna ^a   Krasowska, Anna ^a   Stefanowicz, Piotr ^a   Dziadkowiec, Dorota ^a   Łukaszewicz, Marcin ^a,b  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOIC ACID; FUNGAL EXTRACT; FUNGAL PROTEIN; HEXANOIC ACID; OCTANOIC ACID; PHENETHYL ALCOHOL; PROTEIN CSH1; PROTEIN HWP1; PROTEIN INO1; SACCHAROMYCES BOULARDII EXTRACT; UNCLASSIFIED DRUG; DECANOIC ACID DERIVATIVE; PLASTIC;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FUNGAL METABOLISM; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS HYPHAE; GAS CHROMATOGRAPHY; GENE EXPRESSION PROFILING; MASS SPECTROMETRY; MICROBIAL ADHESION; NONHUMAN; ORGANISMAL INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES BOULARDII; BACTERIUM ADHERENCE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; SACCHAROMYCES; SURFACE PROPERTY;

SACCHAROMYCES BOULARDII;

BACTERIAL ADHESION; BIOFILMS; CANDIDA ALBICANS; DECANOIC ACIDS; GENE EXPRESSION REGULATION, FUNGAL; HYPHAE; PHENYLETHYL ALCOHOL; PLASTICS; SACCHAROMYCES; SURFACE PROPERTIES;

EID: 77957775514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012050     Document Type: Article

References (37)

1. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, et al. (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96: 981-988.
2. Kotowska M, Albrecht P, Szajewska H (2005) Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 21: 583-590.
3. Bleichner G, Blehaut H, Mentec H, Moyse D (1997) Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 23: 517-523.
4. Saint-Marc T, Rossello-Prats L, Touraine JL (1991) [Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS]. Ann Med Interne (Paris) 142: 64-65.
5. Czerucka D, Rampal P (1999) Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells. Dig Dis Sci 44: 2359-2368.
6. Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, et al. (2006) Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res 60: 24-29.
7. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C (1999) Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 67: 302-307.
8. Buts JP, De Keyser N, De Raedemaeker L (1994) Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res 36: 522-527.
9. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
10. Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
11. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
12. Braun BR, Johnson AD (1997) Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277: 105-109.
13. Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17: 255-267.
14. Southern P, Horbul J, Maher D, Davis DA (2008) C. albicans colonization of human mucosal surfaces. PLoS One 3: e2067.
15. Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67: 400-428, table of contents.
16. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122-143, table of contents.
17. Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, et al. (2007) Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot Cell 6: 2429-2436.
18. McLain N, Ascanio R, Baker C, Strohaver RA, Dolan JW (2000) Undecylenic acid inhibits morphogenesis of Candida albicans. Antimicrob Agents Chemother 44: 2873-2875.
19. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP (1972) Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 2: 23-28.
20. Ells R, Kock JL, Van Wyk PW, Botes PJ, Pohl CH (2009) Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis. J Antimicrob Chemother 63: 124-128.
21. Bergsson G, Arnfinnsson J, Steingrimsson O, Thormar H (2001) In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 45: 3209-3212.
22. Clement M, Tremblay J, Lange M, Thibodeau J, Belhumeur P (2007) Whey-derived free fatty acids suppress the germination of Candida albicans in vitro. FEMS Yeast Res 7: 276-285.
23. Jawhara S, Poulain D (2007) Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 45: 691-700.
24. Fidan I, Kalkanci A, Yesilyurt E, Yalcin B, Erdal B, et al. (2009) Effects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicans. Mycoses 52: 29-34.
25. Berg R, Bernasconi P, Fowler D, Gautreaux M (1993) Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J Infect Dis 168: 1314-1318.
26. Krasowska A, Murzyn A, Dyjankiewicz A, Lukaszewicz M, Dziadkowiec D (2009) The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res 9: 1312-1321.
27. Konno N, Ishii M, Nagai A, Watanabe T, Ogasawara A, et al. (2006) Mechanism of Candida albicans transformation in response to changes of pH. Biol Pharm Bull 29: 923-926.
28. Nobile CJ, Nett JE, Andes DR, Mitchell AP (2006) Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 5: 1604-1610.
29. Ene IV, Bennett RJ (2009) Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot Cell 8: 1909-1913.
30. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL (2002) Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68: 5459-5463.
31. Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS, Fonzi WA (1999) HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J Bacteriol 181: 5273-5279.
32. Mille C, Janbon G, Delplace F, Ibata-Ombetta S, Gaillardin C, et al. (2004) Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation. J Biol Chem 279: 47952-47960.
33. Rogers PD, Barker KS (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 47: 1220-1227.
34. Cao YY, Cao YB, Xu Z, Ying K, Li Y, et al. (2005) cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 49: 584-589.
35. Singleton DR, Masuoka J, Hazen KC (2001) Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol 183: 3582-3588.
36. Singleton DR, Fidel PL Jr, Wozniak KL, Hazen KC (2005) Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells. FEMS Microbiol Lett 244: 373-377.
37. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.